Golden Announces New Line of Cannabis Infused Fruit Chews

PORTLAND, Ore., March 08, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced the availability of new edible product line of cannabis infused fruit chews that includes restorative ingredients that inspires wellbeing. Golden, a Portland-based oils and extracts brand within the Golden Leaf portfolio, has developed this new offering in an effort to help its customers to balance life’s highs and lows.



Featuring a combination of premium cannabis oil, real fruit and restorative ingredients, the new fruit chews line will offer four bold, new flavors for consumers to choose from. The initial flavors in the line include:

Tangerine – with real fruit, maca root and B-complex

Tropical Fruit - with real fruit, chamomile and passion flower

Kiwi Strawberry – with real fruit, vitamin D-3 and B-complex

Acai Berry – with real fruit, acai berry antioxidant, goji berry antioxidant and elderberry antioxidant

The new line will bring more variety to the Golden brand of products and aim to deliver delicious tasting edibles that are vegan-friendly, gluten-free and soy-free for the health-conscious, non-smoking cannabis consumer.

“As the cannabis marketplace continues to grow and the population of cannabis consumers continues to expand, we see an opportunity to engage and connect with our customers who prefer to consume cannabis through non-smoking methods. Creating quality products that include natural ingredients, come in a variety of flavors and taste great, shows that we can recognize market trends and offer consumers a variety of options when they walk through our doors,” said William Simpson, founder of Chalice Farms and chief executive officer of Golden Leaf Holdings, Golden’s parent company. “We expect these products to resonate with customers looking for functional edibles that suit their lifestyle.”

At launch, the products will be sold and distributed by the Company’s Oregon wholesale entity as well as in Chalice Farms dispensaries in Oregon. Since its opening in 2014, Chalice Farms has served the greater Portland, OR community with its chain of dispensaries selling its line of 12 premium edibles.

To be added to the distribution list please email GLH@kcsa.com with “GLH” in the subject line.

About Golden Leaf Holdings

Golden Leaf Holdings Ltd., a Canadian company with operations in multiple jurisdictions including Oregon, Nevada and Canada, is one of the largest cannabis oil and solution providers in North America, and a leading cannabis products company built around recognized brands. Golden Leaf Holdings cultivates, extracts and manufactures and distributes its products through its branded Chalice Farm retail dispensaries, as well as through third party dispensaries. Golden Leaf leverages a strong management team with cannabis and food industry experience to complement its expertise in extracting, refining and selling cannabis oil. Visit http://goldenleafholdings.com/ to learn more.

Investor Relations:

Steve Silver / Phil Carlson

GLH@kcsa.com

212-896-1220 / 212-896-1233

Media Relations:

Anne Donohoe / Nick Opich

KCSA Strategic Communications

adonohoe@kcsa.com / nopich@kcsa.com

212-896-1265 / 212-896-1206

Company:

William Simpson

Chief Executive Officer

Golden Leaf Holdings Ltd.

503-477-7626

William@chalicefarms.com

Disclaimer: This press release contains "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the Company’s future business operation, expectations of gross sales, the opinions or beliefs of management and future business goals, statements regarding the timing for the beginning of cultivation at the St. Thomas facility, expectations of additional shipments of plants, the expected timing of the commencement of adult-use market sales in Canada, and the expected timing for receipt of the Company’s sales license from Health Canada. Generally, forward looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to general business, economic and competitive uncertainties, regulatory risks including risks related to the expected timing of the Company’s participation in the adult use market, market risks, risks inherent in manufacturing operations and other risks of the cannabis industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking information. Forward-looking information is provided herein for the purpose of presenting information about management’s current expectations relating to the future and readers are cautioned that such information may not be appropriate for other purpose. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws. This press release does not constitute an offer of securities for sale in the United States, and such securities may not be offered or sold in the United States absent registration or an exemption from registration or an exemption from registration.